{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:54:30Z","timestamp":1783464870634,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00520-020-05518-6","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T18:13:45Z","timestamp":1589480025000},"page":"509-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of cardiovascular comorbidities on inpatient mortality in patients hospitalized with neutropenic fever"],"prefix":"10.1007","volume":"29","author":[{"given":"Suheil Albert","family":"Atallah-Yunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis John","family":"Kadado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris","family":"Haddadin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Hernandez-Montfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"issue":"4","key":"5518_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56\u2013e93","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5518_CR2","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3111\/13696998.2013.782034","volume":"16","author":"B Dulisse","year":"2013","unstructured":"Dulisse B, Li X, Gayle JA, Barron RL, Ernst FR, Rothman KJ, Legg JC, Kaye JA (2013) A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia. J Med Econ 16(6):720\u2013735","journal-title":"J Med Econ"},{"issue":"2","key":"5518_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncr.11882","volume":"100","author":"J Crawford","year":"2004","unstructured":"Crawford J, Dale DC, Lyman GH (2004) Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 100(2):228\u2013237","journal-title":"Cancer."},{"issue":"1","key":"5518_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bjhh.2014.11.012","volume":"37","author":"M Boada Burutaran","year":"2015","unstructured":"Boada Burutaran M, Guadagna R, Grille S, Stevenazzi M, Guillermo C, Diaz L (2015) Results of high-risk neutropenia therapy of hematology-oncology patients in a university hospital in Uruguay. Rev Bras Hematol Hemoter 37(1):28\u201333","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"Suppl 1","key":"5518_CR5","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/383050","volume":"39","author":"J Klastersky","year":"2004","unstructured":"Klastersky J (2004) Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 39(Suppl 1):S32\u2013S37","journal-title":"Clin Infect Dis"},{"key":"5518_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1472-6963-14-162","volume":"14","author":"T Perron","year":"2014","unstructured":"Perron T, Emara M, Ahmed S (2014) Time to antibiotics and outcomes in cancer patients with febrile neutropenia. BMC Health Serv Res 14:162","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"5518_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/1078155213492450","volume":"20","author":"D Weycker","year":"2014","unstructured":"Weycker D, Barron R, Kartashov A, Legg J, Lyman GH (2014) Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings. J Oncol Pharm Pract 20(3):190\u2013198","journal-title":"J Oncol Pharm Pract"},{"issue":"7","key":"5518_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.6004\/jnccn.2016.0093","volume":"14","author":"LR Baden","year":"2016","unstructured":"Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C (2016) Prevention and treatment of cancer-related infections, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 14(7):882\u2013913","journal-title":"J Natl Compr Cancer Netw"},{"issue":"14","key":"5518_CR9","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol 36(14):1443\u20131453","journal-title":"J Clin Oncol"},{"issue":"10","key":"5518_CR10","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 106(10):2258\u20132266","journal-title":"Cancer."},{"key":"5518_CR11","doi-asserted-by":"publisher","unstructured":"Culakova E, Poniewierski MS, Crawford J, Dale DC, Lyman GH (2014) Impact of comorbidities on length of stay and mortality in hospitalized patients with cancer and febrile neutropenia. Blood 124(21):2601. https:\/\/doi.org\/10.1182\/blood.V124.21.2601.2601","DOI":"10.1182\/blood.V124.21.2601.2601"},{"key":"5518_CR12","unstructured":"Houchens RLRD, Elixhauser A, Jiang J (2014) Nationwide inpatient sample redesign final report. U.S. Agency for Healthcare Research and Quality"},{"key":"5518_CR13","doi-asserted-by":"publisher","unstructured":"Kozma CM, Dickson M, Chia V, Legg J, Barron R (2012) Trends in neutropenia-related inpatient events. J Oncol Pract 8(3):149\u2013155. https:\/\/doi.org\/10.1200\/JOP.2011.000360","DOI":"10.1200\/JOP.2011.000360"},{"issue":"6","key":"5518_CR14","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1200\/JOP.2016.019588","volume":"13","author":"E Tai","year":"2017","unstructured":"Tai E, Guy GP, Dunbar A, Richardson LC (2017) Cost of cancer-related neutropenia or fever hospitalizations, United States, 2012. J Oncol Pract 13(6):e552\u2013ee61","journal-title":"J Oncol Pract"},{"issue":"6","key":"5518_CR15","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QCO.0000000000000202","volume":"28","author":"KA Thursky","year":"2015","unstructured":"Thursky KA, Worth LJ (2015) Can mortality of cancer patients with fever and neutropenia be improved? Curr Opin Infect Dis 28(6):505\u2013513","journal-title":"Curr Opin Infect Dis"},{"issue":"25","key":"5518_CR16","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ et al (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368(25):2385\u20132394","journal-title":"N Engl J Med"},{"issue":"4","key":"5518_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/CCO.0b013e328352ead2","volume":"24","author":"S Ahn","year":"2012","unstructured":"Ahn S, Lee YS (2012) Predictive factors for poor prognosis febrile neutropenia. Curr Opin Oncol 24(4):376\u2013380","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"5518_CR18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-2354.2007.00780.x","volume":"16","author":"A Uys","year":"2007","unstructured":"Uys A, Rapoport BL, Fickl H, Meyer PW, Anderson R (2007) Prediction of outcome in cancer patients with febrile neutropenia: comparison of the multinational association of supportive care in cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, \u22126, \u22128 and \u221210. Eur J Cancer Care (Engl) 16(6):475\u2013483","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"9","key":"5518_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.6004\/jnccn.2017.7010","volume":"15","author":"Y Li","year":"2017","unstructured":"Li Y, Family L, Yang SJ, Klippel Z, Page JH, Chao C (2017) Risk of febrile neutropenia associated with select myelosuppressive chemotherapy regimens in a large community-based oncology practice. J Natl Compr Cancer Netw 15(9):1122\u20131130","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"5518_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40959-017-0021-y","volume":"3","author":"A Asnani","year":"2017","unstructured":"Asnani A, Manning A, Mansour M, Ruskin J, Hochberg EP, Ptaszek LM (2017) Management of atrial fibrillation in patients taking targeted cancer therapies. Cardio-Oncology. 3(1):2","journal-title":"Cardio-Oncology."},{"issue":"9","key":"5518_CR21","first-page":"582","volume":"96","author":"JD Gazewood","year":"2017","unstructured":"Gazewood JD, Turner PL (2017) Heart failure with preserved ejection fraction: diagnosis and management. Am Fam Physician 96(9):582\u2013588","journal-title":"Am Fam Physician"},{"issue":"16","key":"5518_CR22","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J, for the Study Section on Infections of Multinational Association for Supportive Care in Cancer (2000) The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038\u20133051","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-020-05518-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-020-05518-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T14:15:42Z","timestamp":1606313742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-020-05518-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5518"],"URL":"https:\/\/doi.org\/10.1007\/s00520-020-05518-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]},"assertion":[{"value":"9 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflict of interest to disclose. Authors have full control of all primary data and data can be provided if requested.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}